Results 141 to 150 of about 280,867 (260)

Conference Report: Cerebellar Development and Disease at Single-Cell Resolution. [PDF]

Cerebellum
Kutscher LM, Aprile D, Bayin NS, Becker EBE, Cerrato V, Turrini G, Coolen M, Cantagrel V, Durand BC, Evans Ii MK, Haldipur P, Millen KJ, Yeung J, Goldowitz D, Hatten ME, Joyner AL, Kebschull JM, Li JYH, Quadrato G, Schmidt C, Sepp M, Silva TP, Testa G, Tiberi L, Mayer S.   +24 more
europepmc   +1 more source

Conference report on the 14th International Society of Paediatric Oncology African Continental Meeting, 16-18 March 2022, Kampala, Uganda. [PDF]

Ecancermedicalscience, 2022
van Heerden J, Irumba LC, Assani K, Downing J, Davidson A, Hessissen L, Schoeman J, Israels T, Cox S, Abdelhafeez H, Arao SO, Parkes J, Balagadde-Kambugu J, Geel J.   +13 more
europepmc   +1 more source

CSF Monoamine Metabolites and Cognitive Trajectory in Early Parkinson's Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Imaging and postmortem studies indicate that abnormalities in monoaminergic neurotransmission contribute to cognitive impairment in Parkinson's disease (PD). However, it remains uncertain if cerebrospinal fluid (CSF) monoamine metabolites can serve as biomarkers of cognitive decline in early PD.
Jing‐Yu Shao, Rong Li, Yu‐Xiang Jiao, Kai Ma, Hong‐Qi Yang, Zheng‐Yu Sun, Jie‐Wen Zhang, Shuai Chen   +7 more
wiley   +1 more source

The 4th annual American Society for Intercellular Communication (ASIC) meeting, 2024 conference report. [PDF]

Extracell Vesicles Circ Nucl Acids
Russell AE, Lorico A.
europepmc   +1 more source

Clinical Outcomes of SEEG‐Guided Radiofrequency Thermocoagulation in Children With Focal Drug‐Resistant Epilepsy: A Multicenter Real‐World Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Stereoelectroencephalography‐guided radiofrequency thermocoagulation (SEEG‐RFTC) has emerged as a safe and effective minimally invasive treatment for children with drug‐resistant focal epilepsy. Although evidence from real‐world studies remains limited, numerous pediatric cases have demonstrated promising outcomes. This retrospective
Weitao Chen, Stéphane Jean, Weihong Liu, Yihai Dai, Xinrong Fang, Xiaoqiang Wei, Shan Chen, Shiwei Song   +7 more
wiley   +1 more source

Conference report of the 2024 Antimicrobial Resistance Meeting. [PDF]

NPJ Antimicrob Resist
Chong CE, Pham TM, Carey ME, Wee BA, Taouk ML, Favieres JF, Moore CE, Dyson ZA, Lim C, Brown CL, Williamson D, Opatowski L, Outterson K, Mukiri KM, Sherry NL, Essack SY, Brisse S, Grad YH, Baker KS.   +18 more
europepmc   +1 more source

An overview of the challenges and key initiatives in hepatology practice in the UK in 2022: a cautionary tale, but reasons for optimism - British Association for the Study of the Liver (BASL) Annual Meeting 2022 Conference Report. [PDF]

Clin Med (Lond), 2023
Wells G, Spiers J, Williams FR, Li W, Tavabie OD, Brennan PN.   +5 more
europepmc   +1 more source

GAD65 Antibody ELISA With Extended Reportable Range: Validation and Guidance for Neurological Practice

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To (1) validate GAD65‐ELISA detection and quantification for type 1 diabetes mellitus and autoimmune neurological diagnoses, (2) correlate ELISA results (reference range < 5 IU/mL) with established radioimmunoprecipitation assay (RIA; ≤ 0.02 nmol/L), and (3) define ELISA clinical utility and pitfalls.
Andrew McKeon, Dana Olofson, Diana Anissian, Divyanshu Dubey, Eoin P. Flanagan, Max C. Herman, Sarosh R. Irani, Daniel H. Lachance, Maria A. Willrich, Sean Pittock, John R. Mills, Anastasia Zekeridou   +11 more
wiley   +1 more source

Efficacy of Inebilizumab in N‐MOmentum Trial Participants With or Without Prior Immunosuppressants

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT This post hoc analysis examined the impact of prior immunosuppressants on the long‐term efficacy and safety of inebilizumab, a cluster of differentiation 19+ B‐cell–depleting monoclonal antibody, in participants with aquaporin‐4–seropositive neuromyelitis optica spectrum disorder from the N‐MOmentum trial (NTC02200770).
Bruce A. C. Cree, Beatrice Suero, Sarah Walsh, Romain Marignier, John W. Lindsey, Ho Jin Kim, Dewei She, Daniel Cimbora, Dustin Cavida, Friedemann Paul   +9 more
wiley   +1 more source

Enhancing participation of historically minoritized groups in Alzheimer disease and related dementias research: National Conference Report. [PDF]

Alzheimers Dement
Mozersky J, Dimtsu Assfaw A, Balls Berry JE, Moulder KL, Denny A, Aranda M, Asthana S, Babulal G, Berry B, Boyd A, Buchwald D, Croff R, Flatt J, Gabel M, Gleason CE, Glover CM, Green-Harris G, Hudson D, Jackson J, Johnson DK, Medina L, Mendez S, O'Bryant S, Park VT, Parker MW, Petty D, Stites SD, Streitz ML, Ushe M, Wilkins CH, Zuelsdorff M, Morris JC.   +31 more
europepmc   +1 more source